SG149052A1 - Nicotinic acetylcholine receptor ligands - Google Patents
Nicotinic acetylcholine receptor ligandsInfo
- Publication number
- SG149052A1 SG149052A1 SG200809495-5A SG2008094955A SG149052A1 SG 149052 A1 SG149052 A1 SG 149052A1 SG 2008094955 A SG2008094955 A SG 2008094955A SG 149052 A1 SG149052 A1 SG 149052A1
- Authority
- SG
- Singapore
- Prior art keywords
- acetylcholine receptor
- receptor ligands
- nicotinic acetylcholine
- psychotic
- prophylaxis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53171203P | 2003-12-22 | 2003-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG149052A1 true SG149052A1 (en) | 2009-01-29 |
Family
ID=34710246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200809495-5A SG149052A1 (en) | 2003-12-22 | 2004-12-20 | Nicotinic acetylcholine receptor ligands |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20070270458A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1699786A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007515478A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20060125812A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1914201A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004303737A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0417927A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2550844A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL176071A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA06007026A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20063356L (cg-RX-API-DMAC7.html) |
| SG (1) | SG149052A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005061494A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200605074B (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2582339C2 (ru) | 2010-05-27 | 2016-04-27 | Таргасепт, Инк. | Неконкурентные антагонисты никотиновых рецепторов |
| EP2593447B1 (de) | 2010-07-15 | 2016-08-17 | Bayer Intellectual Property GmbH | 3-pyridyl-heteroarylcarboxamidverbindungen als schädlingsbekämpfungsmittel |
| CA3169697A1 (en) * | 2020-02-28 | 2021-09-02 | Dominic Reynolds | Thiophenyl derivatives useful for modulating nucleic acid splicing |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2529548A1 (fr) * | 1982-07-02 | 1984-01-06 | Delalande Sa | Nouveaux derives de l'amino-3 quinuclidine, leur procede et leur application en therapeutique |
| EP0287196B1 (en) * | 1987-02-18 | 1994-11-23 | Beecham Group Plc | Indole derivatives, process for their preparation and pharmaceutical compositions containing them |
| SE0000540D0 (sv) * | 2000-02-18 | 2000-02-18 | Astrazeneca Ab | New compounds |
| WO2002015662A2 (en) * | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists |
| WO2002017358A2 (en) * | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists) |
| JP2004506734A (ja) * | 2000-08-21 | 2004-03-04 | ファルマシア・アンド・アップジョン・カンパニー | 疾患治療用のキヌクリド置換ヘテロアリール部分 |
| DE10156719A1 (de) * | 2001-11-19 | 2003-05-28 | Bayer Ag | Heteroarylcarbonsäureamide |
-
2004
- 2004-12-20 MX MXPA06007026A patent/MXPA06007026A/es unknown
- 2004-12-20 JP JP2006546908A patent/JP2007515478A/ja not_active Abandoned
- 2004-12-20 AU AU2004303737A patent/AU2004303737A1/en not_active Abandoned
- 2004-12-20 US US10/583,582 patent/US20070270458A1/en not_active Abandoned
- 2004-12-20 WO PCT/SE2004/001940 patent/WO2005061494A1/en not_active Ceased
- 2004-12-20 BR BRPI0417927-7A patent/BRPI0417927A/pt not_active IP Right Cessation
- 2004-12-20 SG SG200809495-5A patent/SG149052A1/en unknown
- 2004-12-20 CA CA002550844A patent/CA2550844A1/en not_active Abandoned
- 2004-12-20 CN CNA2004800412932A patent/CN1914201A/zh active Pending
- 2004-12-20 KR KR1020067012361A patent/KR20060125812A/ko not_active Withdrawn
- 2004-12-20 EP EP04809113A patent/EP1699786A1/en not_active Withdrawn
-
2006
- 2006-05-31 IL IL176071A patent/IL176071A0/en unknown
- 2006-06-20 ZA ZA200605074A patent/ZA200605074B/en unknown
- 2006-07-19 NO NO20063356A patent/NO20063356L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200605074B (en) | 2007-05-30 |
| WO2005061494A1 (en) | 2005-07-07 |
| US20070270458A1 (en) | 2007-11-22 |
| MXPA06007026A (es) | 2006-08-31 |
| KR20060125812A (ko) | 2006-12-06 |
| CA2550844A1 (en) | 2005-07-07 |
| AU2004303737A1 (en) | 2005-07-07 |
| BRPI0417927A (pt) | 2007-04-17 |
| EP1699786A1 (en) | 2006-09-13 |
| IL176071A0 (en) | 2006-10-05 |
| NO20063356L (no) | 2006-09-21 |
| JP2007515478A (ja) | 2007-06-14 |
| CN1914201A (zh) | 2007-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200508214A (en) | Novel compounds | |
| TW200613243A (en) | Novel compounds | |
| TNSN05194A1 (en) | Substituted n-arylheterocycles, method for production and use thereof as medicaments | |
| NO20050525L (no) | Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer | |
| DE602004021472D1 (en) | Pyrimiidinverbindungen | |
| SE0202539D0 (sv) | Compounds | |
| GEP20084551B (en) | 4-phenylamino-quinazolin-6-yl-amides | |
| IL229136A (en) | Process for making mek inhibitors | |
| EP1633740A4 (en) | CHEMICAL COMPOUNDS | |
| MXPA05008690A (es) | Derivados de adamantano, procedimientos para su preparacion y composiciones farmaceuticas que los contienen. | |
| TW200640908A (en) | Chemical compounds | |
| TW200621751A (en) | Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors | |
| TW200800999A (en) | Novel compounds | |
| SE0104140D0 (sv) | Novel Compounds | |
| IL185611A0 (en) | Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same | |
| TW200616995A (en) | Novel compounds | |
| GEP20115231B (en) | 2-amino-7,8-dihydro-6h-pyrido [4,3-d] pyrimidin-5-ones | |
| IL188942A0 (en) | Benzimidazole derivatives and pharmaceutical compositions containing the same | |
| MX2010006748A (es) | Pirazolo[1,5-a]pirimidinas utiles como inhibidores de jak2. | |
| MY135850A (en) | Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use | |
| TW200738659A (en) | Novel compounds | |
| MX2007010414A (es) | Derivados de piridin-2-carboxamida como antagonistas de mglur5. | |
| TW200604197A (en) | New compounds | |
| MXPA05011785A (es) | Moduladores positivos de receptores de acetilcolina nicotinicos. | |
| TNSN07440A1 (en) | Derivatives of pyrido [2,3 -d] pyrimidine, the preparation thereof, and the therapeutic application of the same |